geneXpert, is the India late?

Kapil M Gandha
{"title":"geneXpert, is the India late?","authors":"Kapil M Gandha","doi":"10.24896/JRMDS.V1I1.7","DOIUrl":null,"url":null,"abstract":"The Xpert MTB/RIF – a rapid, fullyautomated nucleic acid amplification test – is the first major breakthrough in tuberculosis (TB) diagnostics since sputum smear microscopy was developed more than 100 years ago. Further more in case of HIV positive patient’s sputum microcopy has less sensitivity and culture takes three to six month while this test detects TB and Rifampicin resistance directly from untreated sputum in less than two hours. India is a country with a high burden of tuberculosis, multidrug-resistant tuberculosis and tuberculosis–HIV coinfection.  By early diagnosis of resistance and at the pt care site only this intervention would reduce the transmission of primary drug resistance TB and would decrease mortality and morbidity.","PeriodicalId":17001,"journal":{"name":"Journal of Research in Medical and Dental Science","volume":"1 1","pages":"27-28"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Research in Medical and Dental Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24896/JRMDS.V1I1.7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The Xpert MTB/RIF – a rapid, fullyautomated nucleic acid amplification test – is the first major breakthrough in tuberculosis (TB) diagnostics since sputum smear microscopy was developed more than 100 years ago. Further more in case of HIV positive patient’s sputum microcopy has less sensitivity and culture takes three to six month while this test detects TB and Rifampicin resistance directly from untreated sputum in less than two hours. India is a country with a high burden of tuberculosis, multidrug-resistant tuberculosis and tuberculosis–HIV coinfection.  By early diagnosis of resistance and at the pt care site only this intervention would reduce the transmission of primary drug resistance TB and would decrease mortality and morbidity.
geneXpert,印度迟到了吗?
Xpert MTB/RIF是一种快速、全自动核酸扩增测试,是自100多年前开发痰涂片显微镜以来,结核病诊断的第一个重大突破。此外,在HIV阳性患者的情况下,痰涂片的敏感性较低,培养需要三到六个月,而这种检测可以在不到两小时的时间内直接从未经治疗的痰中检测出结核病和利福平耐药性。印度是一个结核病、耐多药结核病和结核病-艾滋病合并感染负担沉重的国家。通过耐药性的早期诊断,只有在pt护理点进行这种干预才能减少原发耐药结核病的传播,并降低死亡率和发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Research in Medical and Dental Science
Journal of Research in Medical and Dental Science MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
0
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信